FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200174887> ?p ?o ?g. }

• W3200174887 endingPage "e1552" @default.
• W3200174887 startingPage "e1539" @default.
• W3200174887 abstract "Given the increasing prevalence of diabetes in low-income and middle-income countries (LMICs), we aimed to estimate the health and cost implications of achieving different targets for diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among LMICs.We constructed a microsimulation model to estimate disability-adjusted life-years (DALYs) lost and health-care costs of diagnosis, treatment, and control of blood pressure, dyslipidaemia, and glycaemia among people with diabetes in LMICs. We used individual participant data-specifically from the subset of people who were defined as having any type of diabetes by WHO standards-from nationally representative, cross-sectional surveys (2006-18) spanning 15 world regions to estimate the baseline 10-year risk of atherosclerotic cardiovascular disease (defined as fatal and non-fatal myocardial infarction and stroke), heart failure (ejection fraction of <40%, with New York Heart Association class III or IV functional limitations), end-stage renal disease (defined as an estimated glomerular filtration rate <15 mL/min per 1·73 m2 or needing dialysis or transplant), retinopathy with severe vision loss (<20/200 visual acuity as measured by the Snellen chart), and neuropathy with pressure sensation loss (assessed by the Semmes-Weinstein 5·07/10 g monofilament exam). We then used data from meta-analyses of randomised controlled trials to estimate the reduction in risk and the WHO OneHealth tool to estimate costs in reaching either 60% or 80% of diagnosis, treatment initiation, and control targets for blood pressure, dyslipidaemia, and glycaemia recommended by WHO guidelines. Costs were updated to 2020 International Dollars, and both costs and DALYs were computed over a 10-year policy planning time horizon at a 3% annual discount rate.We obtained data from 23 678 people with diabetes from 67 countries. The median estimated 10-year risk was 10·0% (IQR 4·0-18·0) for cardiovascular events, 7·8% (5·1-11·8) for neuropathy with pressure sensation loss, 7·2% (5·6-9·4) for end-stage renal disease, 6·0% (4·2-8·6) for retinopathy with severe vision loss, and 2·6% (1·2-5·3) for congestive heart failure. A target of 80% diagnosis, 80% treatment, and 80% control would be expected to reduce DALYs lost from diabetes complications from a median population-weighted loss to 1097 DALYs per 1000 population over 10 years (IQR 1051-1155), relative to a baseline of 1161 DALYs, primarily from reduced cardiovascular events (down from a median of 143 to 117 DALYs per 1000 population) due to blood pressure and statin treatment, with comparatively little effect from glycaemic control. The target of 80% diagnosis, 80% treatment, and 80% control would be expected to produce an overall incremental cost-effectiveness ratio of US$1362 per DALY averted (IQR 1304-1409), with the majority of decreased costs from reduced cardiovascular event management, counterbalanced by increased costs for blood pressure and statin treatment, producing an overall incremental cost-effectiveness ratio of $1362 per DALY averted (IQR 1304-1409).Reducing complications from diabetes in LMICs is likely to require a focus on scaling up blood pressure and statin medication treatment initiation and blood pressure medication titration rather than focusing on increasing screening to increase diabetes diagnosis, or a glycaemic treatment and control among people with diabetes.None." @default.
• W3200174887 created "2021-09-27" @default.
• W3200174887 creator A5000278382 @default.
• W3200174887 creator A5003130407 @default.
• W3200174887 creator A5003138186 @default.
• W3200174887 creator A5011819203 @default.
• W3200174887 creator A5011942396 @default.
• W3200174887 creator A5013481506 @default.
• W3200174887 creator A5025277130 @default.
• W3200174887 creator A5029635780 @default.
• W3200174887 creator A5035870050 @default.
• W3200174887 creator A5035945329 @default.
• W3200174887 creator A5039065157 @default.
• W3200174887 creator A5040203369 @default.
• W3200174887 creator A5041478034 @default.
• W3200174887 creator A5048211551 @default.
• W3200174887 creator A5049061957 @default.
• W3200174887 creator A5049209532 @default.
• W3200174887 creator A5050649371 @default.
• W3200174887 creator A5056900213 @default.
• W3200174887 creator A5057245327 @default.
• W3200174887 creator A5081490685 @default.
• W3200174887 creator A5082997556 @default.
• W3200174887 creator A5088459011 @default.
• W3200174887 creator A5090105475 @default.
• W3200174887 date "2021-11-01" @default.
• W3200174887 modified "2023-10-18" @default.
• W3200174887 title "Estimated effect of increased diagnosis, treatment, and control of diabetes and its associated cardiovascular risk factors among low-income and middle-income countries: a microsimulation model" @default.
• W3200174887 cites W1570393364 @default.
• W3200174887 cites W2104928026 @default.
• W3200174887 cites W2143025931 @default.
• W3200174887 cites W2158543557 @default.
• W3200174887 cites W2405865873 @default.
• W3200174887 cites W2519631090 @default.
• W3200174887 cites W2528802374 @default.
• W3200174887 cites W2558623921 @default.
• W3200174887 cites W2604339437 @default.
• W3200174887 cites W2730331548 @default.
• W3200174887 cites W2743505738 @default.
• W3200174887 cites W2778919216 @default.
• W3200174887 cites W2918851286 @default.
• W3200174887 cites W2971515944 @default.
• W3200174887 cites W3003227613 @default.
• W3200174887 cites W3102506182 @default.
• W3200174887 cites W3165161730 @default.
• W3200174887 cites W4235479662 @default.
• W3200174887 doi "https://doi.org/10.1016/s2214-109x(21)00340-5" @default.
• W3200174887 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8526364" @default.
• W3200174887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34562369" @default.
• W3200174887 hasPublicationYear "2021" @default.
• W3200174887 type Work @default.
• W3200174887 sameAs 3200174887 @default.
• W3200174887 citedByCount "21" @default.
• W3200174887 countsByYear W32001748872022 @default.
• W3200174887 countsByYear W32001748872023 @default.
• W3200174887 crossrefType "journal-article" @default.
• W3200174887 hasAuthorship W3200174887A5000278382 @default.
• W3200174887 hasAuthorship W3200174887A5003130407 @default.
• W3200174887 hasAuthorship W3200174887A5003138186 @default.
• W3200174887 hasAuthorship W3200174887A5011819203 @default.
• W3200174887 hasAuthorship W3200174887A5011942396 @default.
• W3200174887 hasAuthorship W3200174887A5013481506 @default.
• W3200174887 hasAuthorship W3200174887A5025277130 @default.
• W3200174887 hasAuthorship W3200174887A5029635780 @default.
• W3200174887 hasAuthorship W3200174887A5035870050 @default.
• W3200174887 hasAuthorship W3200174887A5035945329 @default.
• W3200174887 hasAuthorship W3200174887A5039065157 @default.
• W3200174887 hasAuthorship W3200174887A5040203369 @default.
• W3200174887 hasAuthorship W3200174887A5041478034 @default.
• W3200174887 hasAuthorship W3200174887A5048211551 @default.
• W3200174887 hasAuthorship W3200174887A5049061957 @default.
• W3200174887 hasAuthorship W3200174887A5049209532 @default.
• W3200174887 hasAuthorship W3200174887A5050649371 @default.
• W3200174887 hasAuthorship W3200174887A5056900213 @default.
• W3200174887 hasAuthorship W3200174887A5057245327 @default.
• W3200174887 hasAuthorship W3200174887A5081490685 @default.
• W3200174887 hasAuthorship W3200174887A5082997556 @default.
• W3200174887 hasAuthorship W3200174887A5088459011 @default.
• W3200174887 hasAuthorship W3200174887A5090105475 @default.
• W3200174887 hasBestOaLocation W32001748871 @default.
• W3200174887 hasConcept C126322002 @default.
• W3200174887 hasConcept C127413603 @default.
• W3200174887 hasConcept C134018914 @default.
• W3200174887 hasConcept C194828623 @default.
• W3200174887 hasConcept C22212356 @default.
• W3200174887 hasConcept C2780015235 @default.
• W3200174887 hasConcept C2780645631 @default.
• W3200174887 hasConcept C555293320 @default.
• W3200174887 hasConcept C71924100 @default.
• W3200174887 hasConcept C78519656 @default.
• W3200174887 hasConcept C84393581 @default.
• W3200174887 hasConcept C99454951 @default.
• W3200174887 hasConceptScore W3200174887C126322002 @default.
• W3200174887 hasConceptScore W3200174887C127413603 @default.
• W3200174887 hasConceptScore W3200174887C134018914 @default.
• W3200174887 hasConceptScore W3200174887C194828623 @default.
• W3200174887 hasConceptScore W3200174887C22212356 @default.
• W3200174887 hasConceptScore W3200174887C2780015235 @default.

• next